Company:  ALIMERA SCIENCES INC (ALIM)
Form Type:  10-Q
Filing Date:  5/11/2012 
CIK:  0001267602 
Address:  6120 WINDWARD PARKWAY
STE 290
 
City, State, Zip:  ALPHARETTA, Georgia 30005 
Telephone:  (678) 990-5740 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.14  
Change: 
0.03 (0.49%)  
Trade Time: 
Apr 24  
Market Cap: 
$247.45M
Description of Business
Alimera Sciences, Inc., and its subsidiaries (we, Alimera or the Company), is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. We are presently focused on diseases affecting the back of the eye, or retina, because we believe these diseases are not well treated with current therapies and represent a significant market opportunity. Our only commercial product is ILUVIEN�, which has received marketing authorization in Austria, the United Kingdom, Portugal, France, Germany and Spain, and has been recommended for marketing authorization in Italy, for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1 Interim Condensed Financial Statements (unaudited)
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO FINANCIAL STATEMENTS
      ITEM 2 Management's Discussion and Analysis of Financial ...
      ITEM 3 Qualitative and Quantitative Disclosures about Market ...
      ITEM 4 Controls and Procedures
    PART II. OTHER INFORMATION
      ITEM 1 Legal Proceedings
      ITEM 1A Risk Factors
      ITEM 2 Unregistered Sales of Equity Securities and Use of ...
      ITEM 3 Defaults Upon Senior Securities
      ITEM 4 Mine Safety Disclosures
      ITEM 5 Other Information
      ITEM 6 Exhibits
    SIGNATURES
    EXHIBIT INDEX
  EXHIBIT 10.35
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    Certification
BROKERAGE PARTNERS